Connect with us
Byron Bay News and Weather copy
The Northern Rivers News
Mt Warning News and Weather copy
The Northern Rivers Weekly Advertising
Kyogle News
Grafton News and Events copy
The Northern Rivers Funerals
Byron Bay News and Weather copy
The Northern Rivers News
Mt Warning News and Weather copy
The Northern Rivers Weekly Advertising
Kyogle News
Grafton News and Events copy
The Northern Rivers Funerals
previous arrow
next arrow

Health News

Government Grants $50 Million for Australian Scientists Pioneering World’s First Long-Term Artificial Heart

Published

on

BiVACOR Total Artificial Heart

Government Grants $50 Million for Australian Scientists Pioneering World’s First Long-Term Artificial Heart

 

In a landmark initiative poised to revolutionise cardiovascular medicine, Australian scientists are spearheading the development of the world’s first long-term artificial heart. With a significant boost from the federal government, which has pledged a grant of $50 million towards the project, researchers are advancing towards a transformative breakthrough in cardiac care.

The artificial heart, conceptualised as an off-the-shelf alternative to organ donation, holds immense promise for patients suffering from end-stage heart failure. For individuals like Jayden Cummins, whose life was irrevocably altered by a viral infection that led to severe heart deterioration, the prospect of a long-term solution represents a beacon of hope.

Cummins, a Sydney-based filmmaker, vividly recounts his battle with heart failure, attributing it to a viral assault that left him operating at a mere 7 percent heart function. While he underwent a temporary solution with a Left Ventricular Assist Device (LVAD) followed by a heart transplant, his journey underscores the critical need for innovative interventions to address the scarcity of donor organs.

Advertisements

Enter Dr. Daniel Timms and his team of bio scientists, who’s pioneering BiVACOR Total Artificial Heart promises to be a game-changer in the field of cardiac medicine. Unlike conventional devices that mimic the pumping action of the natural heart using balloons prone to wear and tear, the BiVACOR heart utilises magnetic levitation technology to propel blood circulation efficiently.

Dr. Timms elucidates on the innovative design, likening it to the magnetically levitated trains in Japan and China, which ensure smooth and frictionless motion. Supported by a multidisciplinary team, including Associate Professor Shaun Gregory of Monash University’s Artificial Heart Frontiers Program, the project unfolds with regular visits to the local hardware store, where components for heart replication are sourced.

The journey from laboratory bench tops to animal testing has yielded promising results, with the titanium hearts demonstrating remarkable durability and efficacy. Human trials are slated to commence in the United States later this year, marking a significant milestone in the quest for a viable long-term solution to heart failure.

BiVACOR Total Artificial Heart

BiVACOR Total Artificial Heart

Professor Garry Jennings from the Heart Foundation of Australia underscores the urgency of such innovations, citing the stark reality of organ shortages and the pressing need for alternatives. With heart failure claiming one in 50 Australian lives annually and a limited number of heart transplant procedures performed each year, the advent of artificial hearts offers a lifeline to countless patients awaiting salvation.

The federal government’s generous funding injection signals a resounding vote of confidence in Australia’s scientific prowess and commitment to advancing medical innovation. With hopes pinned on accelerated progress, scientists aim to make these groundbreaking devices available to patients within the next few years, heralding a new era of cardiac care.

For transplant recipient Jayden Cummins, the potential impact of these advancements is profound. Reflecting on his journey post-transplant, Cummins marvels at the newfound lease on life, cherishing precious moments with loved ones made possible by the gift of a donor heart. His story serves as a poignant reminder of the transformative power of medical innovation and the enduring spirit of resilience in the face of adversity.

As Australia embarks on this bold frontier of medical innovation, the promise of artificial hearts offers solace to those grappling with the debilitating effects of heart failure, embodying the triumph of human ingenuity and compassion. With each beat of progress, the collective hope is for a future where life-saving technology transcends boundaries, enriching and extending lives with boundless possibility.

KEY FACTS:

  1. Revolutionary Technology: The BiVACOR Total Artificial Heart represents a groundbreaking advancement in cardiovascular medicine. Unlike conventional devices that mimic the pumping action of the natural heart using balloons prone to wear and tear, the BiVACOR heart utilises magnetic levitation technology for efficient blood circulation. This innovative design, inspired by magnetically levitated trains in Japan and China, promises enhanced durability and efficacy, offering hope to countless patients grappling with end-stage heart failure.
  2. Government Funding: The federal government’s pledge of $50 million towards the project underscores its commitment to advancing medical innovation and improving healthcare outcomes. This substantial investment not only signifies confidence in Australia’s scientific prowess but also accelerates progress towards making artificial hearts available to patients within the next few years. Such funding injections play a pivotal role in driving research initiatives and fostering collaboration between academia, industry, and government entities.
  3. Human Impact: Jayden Cummins’ personal journey serves as a poignant testament to the transformative potential of medical innovation. Having navigated the harrowing challenges of end-stage heart failure and subsequent transplantation, Cummins embodies resilience and hope. His story highlights the profound impact of artificial hearts on patients’ lives, offering a lifeline to individuals awaiting organ transplantation. Through advancements in medical technology, Cummins and countless others find solace and renewed optimism for the future, underscoring the profound human dimension of scientific progress.

 

For more health news, click here.

Advertisements
Tenterfield-The Bowlo

Health News

New research partnership to tackle hearing loss

Published

on

By

Hearing loss

New research partnership to tackle hearing loss

 

An exciting new collaboration has been established between the Ear Science Institute Australia and the National Acoustic Laboratories (NAL), uniting Australia’s leading hearing researchers in a concerted effort to enhance treatments for the millions affected by hearing impairments.

National Acoustics Laboratories Director, Brent Edwards, emphasised the significance of the collaboration, stating, “This partnership harnesses the collective expertise of some of Australia’s most dedicated and forward-thinking hearing researchers, all committed to profoundly improving hearing healthcare globally.”

Hearing loss is among the world’s most prevalent health issues, with projections suggesting that by 2050 nearly 2.5 billion individuals will experience some form of hearing impairment. This partnership aims to foster substantial advancements in the quality of life for those affected by hearing loss, both in Australia and worldwide.

Advertisements

By pooling their vast resources and data, both institutions are poised to transform hearing health care. The Ear Science Institute Australia, recognised globally as a for-purpose center of excellence, combines scientific research, medical innovation, and clinical practice to pioneer new treatments for ear and hearing conditions, ultimately striving to discover a cure for hearing loss.

Ear Science Institute’s CEO, Sandra Bellekom, commented on the future implications of the partnership, “Looking forward, this alliance with National Acoustic Laboratories opens new pathways for sharing knowledge, which will enhance the delivery of cutting-edge, personalised hearing solutions and expand access to superior hearing care for people around the world.”

 

For more health news, click here.

Advertisements
Tenterfield-The Bowlo
Continue Reading

Health News

Introduction of New Clinical Care Standard by ACSQHC to Address Psychotropic Medicine Use in Cognitive Disability and Impairment

Published

on

By

New Clinical Care Standard

Introduction of New Clinical Care Standard by ACSQHC to Address Psychotropic Medicine Use in Cognitive Disability and Impairment

 

By Jeff Gibbs

The Australian Commission on Safety and Quality in Health Care (the Commission) has today announced the launch of a pivotal new national standard aimed at enhancing the care for individuals with cognitive disabilities or impairments. The introduction of the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard is a critical advancement in promoting safer and more effective treatment protocols across the healthcare spectrum.

Background and Rationale for the New Standard

Advertisements

Recent decades have witnessed a 60% surge in the prescription of psychotropic medications across Australia. Despite a modest reduction in antipsychotic use among the elderly—prompted by heightened awareness of associated risks—the prescribing rates remain alarmingly high, particularly among vulnerable populations. Notably, older individuals and those residing in aged care facilities are disproportionately affected by the adverse effects of these medications, including cognitive decline, heightened risk of falls, strokes, and mortality. Additionally, approximately one-third of individuals with intellectual disabilities are prescribed psychotropic drugs, exposing them to potentially severe short and long-term side effects.

Scope and Impact of the Standard

The new Standard seeks to mitigate the inappropriate utilisation of psychotropic medications and emphasises patient safety. It priorities non-pharmacological interventions as the foremost approach for managing challenging behaviours such as aggression and agitation. Psychotropic medications are advised as a last-resort measure, following the ineffectiveness of alternative strategies or in situations posing significant risk to the individual or others.

The Standard advocates for tailored non-medication strategies that respect the individual’s needs and preferences, developed in consultation with their family and other authorised caregivers. This approach underscores the commitment to upholding the dignity and autonomy of individuals with cognitive impairments.

Expert Insights and Support

Key health experts have endorsed the significance of this new Standard. Conjoint Associate Professor Carolyn Hullick, Chief Medical Officer at the Commission, stresses the necessity for mindful prescribing practices given the limited benefits and substantial risks associated with psychotropic medications in this demographic. Professor Julian Trollor from the University of New South Wales and Juanita Breen from the University of Tasmania also highlight the importance of objective-driven prescribing, continuous monitoring, and the potential to reduce medication dosages in favour of non-pharmacological alternatives.

Implementation Across Settings

The Standard is applicable universally across various healthcare settings, including hospitals, aged care facilities, and community services, ensuring that individuals with cognitive disabilities receive consistent and coordinated care irrespective of the setting.

Professor Eddy Strivens emphasises the need for coordinated efforts and effective communication, particularly during care transitions, to maintain continuity and efficacy of treatment plans and to support decision-making processes that honour patient autonomy.

Collaborative Efforts for Enhanced Care

In a collective endeavour to address these issues, the Commission has collaborated with the Aged Care Quality and Safety Commission and the NDIS Quality and Safeguards Commission to issue a Joint Statement against the misuse of psychotropics in managing behaviours in disabled and elderly populations.

Conclusion

The introduction of the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard marks a significant step forward in improving the quality of care and safety for Australians with cognitive disabilities or impairments. It aligns with ongoing efforts to reform health care, aged care, and disability support systems across the nation.

The complete Standard and accompanying resources are available on the Commission’s website here.

 

For more seniors news, click here.

Advertisements
Tenterfield-The Bowlo
Continue Reading

Education

National Walk Safely to School Day Turns 25

Published

on

By

NSW-Northern-Rivers-Breaking-News

National Walk Safely to School Day Turns 25

 

As National Walk Safely to School Day approaches on Friday, 10 May 2024, primary school-aged children across Australia are encouraged to lace up their shoes for a walk towards a healthier future. Celebrating its 25th anniversary, this initiative, championed by the Pedestrian Council of Australia, highlights the myriad benefits of walking and other forms of active transportation, particularly to and from school.

This annual event not only emphasises physical health but also aims to improve road safety, reduce environmental impact, and promote the use of public transport to lessen car dependency near schools. Harold Scruby, Chairman and CEO of the Pedestrian Council of Australia, emphasises the importance of adult supervision for children under 10 when crossing the street, reinforcing the safety aspect of the campaign.

“Walk Safely to School Day is a great opportunity to teach our kids about the benefits of physical activity,” said Scruby. He also pointed to the worrying statistics of childhood obesity, which affects one in four children at critical levels across the nation, according to the latest ABS National Health Survey results from 2017-18. “The best form of physical activity for all Australians is walking regularly. Children need at least 60 minutes of physical activity a day,” he added.

Advertisements

The day is not just about walking; it also encourages schools and parent groups to host healthy breakfast events to start the day nutritiously. This initiative supports the dual goals of fostering healthful eating habits and providing social interaction within the school community.

As the event marks a significant milestone, schools across Australia are gearing up to participate more actively than ever. Parents, teachers, and caregivers are encouraged to get involved, not only to support their children but also to take part in making walking a regular part of their daily routine.

This initiative plays a crucial role in mitigating traffic congestion around school areas, promoting environmental stewardship, and fostering a sense of community. Everyone in the community is invited to support the initiative, helping to instil healthy habits in children that can lead to lifelong benefits.

For more information on how to participate in National Walk Safely to School Day, visit the Pedestrian Council of Australia’s website or contact your local school to see what activities are planned for the day. Join the movement on 10 May and help make a difference in the lives of young Australians.

 

For more Education news, click here.

Advertisements
Tenterfield-The Bowlo
Continue Reading

NRTimes Online

Advertisement

National News Australia

Latest News

Verified by MonsterInsights